Qube Research & Technologies (QRT)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.5K Buy
+400
New +$35.5K ﹤0.01% 3395
2026
Q2
– Sell
-1,500
Closed -$120K – 3647
2026
Q1
$120K Sell
1,500
-400
-21% -$33K ﹤0.01% 3042
2025
Q4
$162K Sell
1,900
-2,200
-54% -$181K ﹤0.01% 3092
2025
Q3
$319K Sell
4,100
-16,300
-80% -$1.27M ﹤0.01% 2837
2025
Q2
$1.6M Buy
20,400
+15,800
+343% +$1.18M ﹤0.01% 2287
2025
Q1
$333K Buy
4,600
+2,800
+156% +$200K ﹤0.01% 2702
2024
Q4
$133K Buy
1,800
+1,200
+200% +$84K ﹤0.01% 2929
2024
Q3
$39.6K Buy
+600
New +$43.6K ﹤0.01% 2892
2023
Q4
– Sell
-3,900
Closed -$270K – 4456
2023
Q3
$270K Buy
+3,900
New +$313K ﹤0.01% 2290

Other funds holding EW

Qube Research & Technologies (QRT)'s EW Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Edwards Lifesciences (EW) stake by 221% in Q3 2026, buying an estimated $81.5M and bringing the position to 1,331,753 shares worth $115M. The position accounts for 0.09% of the portfolio, ranked #250.

Qube Research & Technologies (QRT) first reported a position in EW in Q3 2018 and has held it in 24 quarters since. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Qube Research & Technologies (QRT) held 1,331,753 shares of Edwards Lifesciences worth $115M as of Q3 2026.
  • Qube Research & Technologies (QRT) bought 917,315 Edwards Lifesciences shares in Q3 2026, an estimated $81.5M.
  • Edwards Lifesciences made up 0.09% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #250 holding.
  • Qube Research & Technologies (QRT) first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 24 quarters since.
  • 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.